Initial studies by Schmidt et al. [60] and Giani and Finocchiaro et al. [61] confirmed that CDKN2A HD was present in patients’ tumours and not just in glioma cell lines but did not assess CDKN2B. Here, CDKN2A is linked to central nervous system cancer.